Hydrocortisone and ulinastatin for miliary tuberculosis-induced septic shock and adult respiratory distress syndrome in the intensive care unit
Hydrocortisone and ulinastatin are anti-inflammatory agent. We hereby report the case of a patient of sputum-positive miliary pulmonary tuberculosis that developed adult respiratory distress syndrome with septic shock. The patient was treated with anti-tubercular drugs, antibiotics, inotropes, vasop...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | CHRISMED Journal of Health and Research |
Subjects: | |
Online Access: | http://www.cjhr.org/article.asp?issn=2348-3334;year=2020;volume=7;issue=1;spage=68;epage=70;aulast=Keyal |
id |
doaj-984e4f8a11554d348d9396f410cdd85c |
---|---|
record_format |
Article |
spelling |
doaj-984e4f8a11554d348d9396f410cdd85c2020-11-25T03:01:48ZengWolters Kluwer Medknow PublicationsCHRISMED Journal of Health and Research2348-33342348-506X2020-01-0171687010.4103/cjhr.cjhr_45_19Hydrocortisone and ulinastatin for miliary tuberculosis-induced septic shock and adult respiratory distress syndrome in the intensive care unitNiraj Kumar KeyalManish NakarmiHydrocortisone and ulinastatin are anti-inflammatory agent. We hereby report the case of a patient of sputum-positive miliary pulmonary tuberculosis that developed adult respiratory distress syndrome with septic shock. The patient was treated with anti-tubercular drugs, antibiotics, inotropes, vasopressors, hydrocortisone, and ulinastatin. From this, we want to emphasize that hydrocortisone and ulinastatin can be one of the treatment options in refractory shock patient not responding to conventional treatment but requires randomized controlled trial to confirm the effectiveness of this combination.http://www.cjhr.org/article.asp?issn=2348-3334;year=2020;volume=7;issue=1;spage=68;epage=70;aulast=Keyalhydrocortisonemiliary tuberculosisseptic shockulinastatin |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Niraj Kumar Keyal Manish Nakarmi |
spellingShingle |
Niraj Kumar Keyal Manish Nakarmi Hydrocortisone and ulinastatin for miliary tuberculosis-induced septic shock and adult respiratory distress syndrome in the intensive care unit CHRISMED Journal of Health and Research hydrocortisone miliary tuberculosis septic shock ulinastatin |
author_facet |
Niraj Kumar Keyal Manish Nakarmi |
author_sort |
Niraj Kumar Keyal |
title |
Hydrocortisone and ulinastatin for miliary tuberculosis-induced septic shock and adult respiratory distress syndrome in the intensive care unit |
title_short |
Hydrocortisone and ulinastatin for miliary tuberculosis-induced septic shock and adult respiratory distress syndrome in the intensive care unit |
title_full |
Hydrocortisone and ulinastatin for miliary tuberculosis-induced septic shock and adult respiratory distress syndrome in the intensive care unit |
title_fullStr |
Hydrocortisone and ulinastatin for miliary tuberculosis-induced septic shock and adult respiratory distress syndrome in the intensive care unit |
title_full_unstemmed |
Hydrocortisone and ulinastatin for miliary tuberculosis-induced septic shock and adult respiratory distress syndrome in the intensive care unit |
title_sort |
hydrocortisone and ulinastatin for miliary tuberculosis-induced septic shock and adult respiratory distress syndrome in the intensive care unit |
publisher |
Wolters Kluwer Medknow Publications |
series |
CHRISMED Journal of Health and Research |
issn |
2348-3334 2348-506X |
publishDate |
2020-01-01 |
description |
Hydrocortisone and ulinastatin are anti-inflammatory agent. We hereby report the case of a patient of sputum-positive miliary pulmonary tuberculosis that developed adult respiratory distress syndrome with septic shock. The patient was treated with anti-tubercular drugs, antibiotics, inotropes, vasopressors, hydrocortisone, and ulinastatin. From this, we want to emphasize that hydrocortisone and ulinastatin can be one of the treatment options in refractory shock patient not responding to conventional treatment but requires randomized controlled trial to confirm the effectiveness of this combination. |
topic |
hydrocortisone miliary tuberculosis septic shock ulinastatin |
url |
http://www.cjhr.org/article.asp?issn=2348-3334;year=2020;volume=7;issue=1;spage=68;epage=70;aulast=Keyal |
work_keys_str_mv |
AT nirajkumarkeyal hydrocortisoneandulinastatinformiliarytuberculosisinducedsepticshockandadultrespiratorydistresssyndromeintheintensivecareunit AT manishnakarmi hydrocortisoneandulinastatinformiliarytuberculosisinducedsepticshockandadultrespiratorydistresssyndromeintheintensivecareunit |
_version_ |
1724691849478668288 |